Then, based on functional enrichment analysis of CYP2E1 in TCGA‐glioma, the association between CYP2E1 and tumor immune microenvironment, lipid metabolism, and ferroptosis were explored to explain these findings could translate to a novel strategy to treat glioma patient with gliomas. This evidence concerns the gene CYP2E1 and central nervous system cancer.